# Considerations for Waiver Requests for pH Adjusters in Generic Drug Products Intended for Parenteral, Ophthalmic, or Otic Use:  Guidance for Industry – FDA Guidance

Source: https://www.keypedia.com/guidances/guidance-document/considerations-for-waiver-requests-for-ph-adjusters-in-generic-drug-products-intended-for-parenteral-ophthalmic-or-otic-use-guidance-for-industry/40969c10-8c6c-42cb-b3eb-03f03eb9fa38

> FDA guidance document: Considerations for Waiver Requests for pH Adjusters in Generic Drug Products Intended for Parenteral, Ophthalmic, or Otic Use:  Guidance for Industry. Issue date: November 17, 2025. Get complete insights and analysis.

---

## Details

- Title: Considerations for Waiver Requests for pH Adjusters in Generic Drug Products Intended for Parenteral, Ophthalmic, or Otic Use:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2025-11-17
- Last Changed: 2025-11-17
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2022-D-0108">FDA-2022-D-0108</a>

## Related Documents

- [Physicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in ANDAs](https://www.keypedia.com/guidances/guidance-document/physicochemical-and-structural-q3-characterization-of-topical-drug-products-submitted-in-andas/9120d697-9a7d-4aac-b9ff-98ee81aafa56)
- [Assessing the Effects of Food on Drugs in INDs and NDAs – Clinical Pharmacology Considerations](https://www.keypedia.com/guidances/guidance-document/assessing-the-effects-of-food-on-drugs-in-inds-and-ndas-clinical-pharmacology-considerations/cf110f90-93c7-45c0-8577-4e7a8dc9aedb)
- [Certain Postapproval Requirements and Resources for ANDAs](https://www.keypedia.com/guidances/guidance-document/certain-postapproval-requirements-and-resources-for-andas/114dc69b-dd6a-4c2f-88c6-0386cd92124f)